KRAS and neoplasm: Metastasis-enriched subtypes 1, 2, 5, 6, and 7 exhibited significantly elevated activity in pathways linked to aggressive tumor behavior, including epithelial–mesenchymal transition (EMT), angiogenesis, hypoxia, and KRAS signaling, with subtype 1 showing particularly strong activation of these aggressive phenotypes.